Mast cells were identified as a risk factor in GC, because it promoted angiogenesis and metastasis of GC by releasing lymphangiogenic factors (VEGF-C and VEGF-F) and angiogenic factors (VEGF-A, CXCL8, MMP-9) [31]. The gene discussed is VEGFC; the disease is gastric cancer.